Neuroborreliosis in an HIV-1 positive patient

Infection

Volumn 34, Issue 2, 2006, Pages 100-102

  Cerny R ^a   Machala, L ^b   Bojar, M ^a   Rozsypal, H ^b   Picha D ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; DOXYCYCLINE; PENICILLIN DERIVATIVE; TETRACYCLINE DERIVATIVE;

ADULT; ANTIBODY PRODUCTION; ARTICLE; BANNWARTH SYNDROME; BORRELIA BURGDORFERI; BORRELIA GARINII; CASE REPORT; FACIAL NERVE PARALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LYME DISEASE; MALE; MENINGITIS; PROGNOSIS; RADICULITIS; SUPERINFECTION; WESTERN BLOTTING;

ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; BORRELIA BURGDORFERI GROUP; CEFOTAXIME; CEREBROSPINAL FLUID; HIV INFECTIONS; HIV-1; HUMANS; LYME NEUROBORRELIOSIS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 33646821046     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-006-4134-8     Document Type: Article

References (15)

1. Bratzke B, Stadler R, Gollnick H, Rolfs A, Hoffken G, Preac-Mursic V, Wilske B, Schaart F, Orfanos CE: Borrelia burgdorferi-induced pseudolymphoma with pathogen cultivation in an HIV-1 positive patient. Hautarzt 1989; 40: 504-509.
2. Dudle G, Opravil M, Luthy R, Weber R: Meningitis after acute Borrelia burgdorferi infection in HIV infection. Dtsch Med Wochenschr 1997; 122: 1178-1180.
3. Garcia-Monco JC, Frey HM, Villar BF, Golightly MG, Benach JL: Lyme disease concurrent with human immunodeficiency virus infection. Am J Med 1989; 87: 325-328.
4. Cordoliani F, Vignon_Pennamen MD, Assous MV, Vabres P, Dronne P, Rybojad M, Morel P: Atypical Lyme borreliosis in an HIV-infected man. Brit J Dermatol 1997; 137: 437-439.
5. Lubbe J, Schlupen EM, Fierz W, Panizzon RG, Burg G: Identification of Borrelia afzelii in a juxta-articular fibroid nodule from a human immunodeficiency virus-positive patient with acrodermatitis chronica atrophicans. Arch Dermatol 1995; 131: 1341-1342.
6. Schlesinger I, Mehta H, Arlievsky N: Lyme arthritis in a child with HIV. Orthopedics 2001; 24: 609-610.
7. Anonymous: Cummulative morbidity of selected infections in the Czech Republic. Zprávy CEM 2004; 13: 19.
8. Reiber H, Felgenhauer K: Protein transfer at the blood cerebro-spinal fluid barrier and quantification of the humoral response within the central nervous system. Clin Chem Acta 1987; 163: 319-328.
9. Kaiser R, Lücking C: Intrathecal synthesis of specific antibodies in neuroborreliosis comparison of different ELISA techniques and calculation methods. J Neurol Sci 1993; 118: 64-72.
10. Pícha D, Moravcová L, Marešová V: Intrathecal synthesis of spesific antiborrelial IgG antibodies in the cerebrospinal fluid of patients with neuroborreliosis. Ces a slov Neurol Neurochir 2000; 63/96: 279-282.
11. Smith R, Schoen R, Rahn D: Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologially confirmed erythema migrans.Ann Intern Med 2002; 136: 421-428.
12. Oteo Revuelta JA, Elias Calvo C, Martinez de Artola V, Perez Surribas D: Infection by Borrelia burgdorferi in patients with the human immunodeficiency virus. A diagnostic problem. Med Clin (Barc) 1993; 101: 207-209.
13. Raoult D, Hechemy KE, Baranton G: Cross-reaction with Borrelia burgdorferi antigen of sera from patients with human immunodeficiency virus infection, syphilis, and leptospirosis. J Clin Microbiol 1989; 27: 2152-2155.
14. Hassler D, Schnauffer S, Ehrfeld H, Muller E: Disappearance of specific immune response after successful therapy of chronic Lyme borreliosis. Int J Med Microbiol 2004; 293: 161-164.
15. Pavia C: Current and novel therapies for Lyme disease. Expert Opin Investig Drugs 2003; 12: 1003-1016.